Darbepoetin Alfa Protects the Rat Heart Against Infarction: Dose-Response, Phase of Action, and Mechanisms-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Darbepoetin Alfa Protects the Rat Heart Against Infarction: Dose-Response, Phase of Action, and Mechanisms

Published:2007-06 Issue:6 Volume:49 Page:337-345
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:

Author:

Baker John E,Kozik Deborah,Hsu Anna K,Fu Xiangping,Tweddell James S,Gross Garrett J

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference33 articles.

1. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure.;Mancini;Circulation,2003

2. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations.;Silverberg;J Am Coll Cardiol,2000

3. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling.;Calvillo;Proc Natl Acad Sci U S A,2003

4. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.;Eschbach;N Engl J Med,1987

5. Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways.;Kilic;Faseb J,2005

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular safety of current and emerging drugs to treat anaemia in chronic kidney disease: a safety review;Expert Opinion on Drug Safety;2023-12-02

2. Are all erythropoiesis-stimulating agents created equal?;Nephrology Dialysis Transplantation;2020-03-24

3. Low-Dose Erythropoietin in Patients With ST-Segment Elevation Myocardial Infarction (EPO-AMI-II)　― A Randomized Controlled Clinical Trial ―;Circulation Journal;2018

4. Extrahematopoietic Actions of Erythropoietin;Textbook of Nephro-Endocrinology;2018

5. Novel, selective EPO receptor ligands lacking erythropoietic activity reduce infarct size in acute myocardial infarction in rats;Pharmacological Research;2016-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3